Search results
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Benzinga via Yahoo Singapore Finance· 1 day agoNovo Nordisk A/S (NYSE:NVO), the maker of the popular obesity drug Ozempic, has been reprimanded by...
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer...
Benzinga via Yahoo Singapore Finance· 2 days agoOn Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of...
Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
Zacks via Yahoo Singapore Finance· 5 days agoJakafi is a first-in-class JAK1/JAK2 inhibitor. INCY has a collaboration agreement with the Swiss...